FDA Approved: CELECOXIB — Supplemental Application (Apotex Corp.)

View source ↗

Summary

The FDA approved Apotex Corp.'s supplemental application for celecoxib (generic) under ANDA204197.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Dysmenorrhea
• Juvenile Idiopathic Arthritis
• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

SUPPL AP for CELECOXIB (CELECOXIB)